This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
TAVR vs. Surgery Among Children and Young Adults with Congenital Heart Disease
Thursday, June 16, 2022
Source Name: Cardiovascular Business
New findings published in the American Journal of Cardiology posit that transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are associated with similar short-term outcomes among pediatric patients presenting with congenital heart disease (CHD). However, SAVR patients in the study had “significantly” longer ICU stays and hospitalization times and were more likely to require medications to control their blood pressure following the procedure.